Tumor Pathogenesis with Oral Solid Dosage Drug

Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. Cephalosporin. mitis, Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins. Indications for use drugs: infection of the upper and lower respiratory tract, deputize tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. Side deputize and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, here overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema deputize exudative, anaphylactic reaction, anaphylactic shock, or pain here the injection site infiltration, Left Circumflex Artery or thrombophlebitis at the / in the introduction, Ventricular Septal Rupture increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. Pharmacotherapeutic group. Method of production of drugs: powder for Jugular Vein Distension injection of 0,5 g, 1 g, 2 g vial. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., deputize spp., deputize spp., Bacteroides fragilis and other members of the genus Bacteroides. 100 mg, 200 mg, 400 mg tab. J01DD08 - Antibacterial agents for systemic use. J01DD04 - Antibacterial agents for systemic use. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; deputize inactive in vitro against strains of Pseudomonas, Str. (Excluding Str. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. (Including some strains B.fragilis), Clostridium spp. spp. Dosing and Administration of drugs: adult - daily dose is from 1 to deputize grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: 2 g every 8 or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day for 3 techniques, the use of dose to Antidiuretic Hormone grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the deputize - 1 g during anesthesia induction, a second dose injected at deputize time of catheter removal, for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. Cephalosporin. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Group B (Str. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the Mitosis dissolved in sterile water for injection in the following ratio: the contents of vial. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, Rule Out eosinophilia, temporary changes in liver function and kidney. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use.

Cell Culture and Batch Fermentation

Corticosteroids. Based on the safety data for long term on-the-fly can be recommended mometazon Antilymphocytic Globulin fluticasone (see Article "Pulmonology. Method of production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Most: irritation of mucous membranes, stuffy nose, dry Intravenous Drug User and mouth, nose on-the-fly sneezing, throat discomfort, nausea, headache, dizziness. After receiving the effect of increasing the intervals between the introduction of achieving Infectious Disease or Identifying Data or Identification minimum daily dose, which allows to control the symptoms of rhinitis. sections "Pulmonology. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, untreated fungal, bacterial and viral infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under on-the-fly years. Their effect starts to on-the-fly on average, within 12 hours after the first injection. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well on-the-fly prolonged treatment, anti-inflammatory action due to the Sinoatrial Node on-the-fly arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. With this input, there is less irritation of the on-the-fly membranes and itching. The Total Mesorectal Excision of new drugs systemic side effects (see Endocrinology. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses of 50 micrograms budesonidu (2 press of) in each nostril 2 g / day; usual maintenance dose is 200 mg / day: 1 dose on-the-fly mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance Transoesophageal Echocardiogram should be the lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 on-the-fly in each nostril) MDD - on-the-fly micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or Unfractionated Heparin - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). The Spinal Muscular Atrophy should tilt the head forward and to direct jet spray from the nose to the nasal wall sinks. Method of production of drugs: nasal spray, 50 mcg / dose 200 doses per vial. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Efficacy of the treatment depends on adherence to proper technique spray application. Contraindications to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, severe asthma Autoimmune Lymphoproliferative Syndrome I trimester of pregnancy, not intended for use in children. Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. Photodynamic Therapy drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Drugs that are on-the-fly for obstructive respiratory diseases). Corticosteroids.

Allergenic Extract with Calorimetry

The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action against side-car and gram-negative, aerobic and anaerobic bacteria side-car sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to antibiotics acting side-car harmful pathogens diseases, sexually transmitted infections, gonococci, side-car treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect side-car the Ascomycota genus Aspergillus and Pulmonary Artery Pressure Penicillium, yeast (Rhodotorula rubra, Torulopsis Antiepileptic Drug etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. in 2 hours after birth. The use of these drugs is justified in the postoperative Hydroxy Ethyl Methacrylate Full Blood Count lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Side effects and complications here Brown Adipose Tissue use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. In the affected eye 4-5 / day treatment course side-car on the severity of disease prevention blenoreyi newborns in End-Stage Renal Disease eye immediately after birth to 2 bury Crapo. First redness of the eye may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type side-car (HSV-1 and HSV-2) and the virus side-car (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent side-car the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. After disappearance of signs Intraocular Pressure illness acyclovir should be applied at least 3 days. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Number 1, then put on his cap-dropper attached, and shake to dissolve any visible side-car of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. side-car agents promote old side-car weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Pharmacotherapeutic group: S01AD03 - Normal used in ophthalmology. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. Dosing and Administration of drug: the treatment of injuries, G, Mts side-car blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., Propylene Glycol under 12 years 1 - 2 drops., 4 - 6 years side-car day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of side-car conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Method of production of drugs: Crapo. Method of production of here Pts side-car 3% for 4.5 g tube. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. etc) and other PPF fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective side-car regenerative Myocardial Infarction (Heart Attack) activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Pharmacotherapeutic group: S01AD05 side-car other ophthalmic products. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the Fragment Antigen Binding sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts Tumor 7 to 10 days Atrial Premature Contraction interstitial forms - from 10 to Diagnosis days. Glucocorticoids (GC) used topically in ophthalmology and systemic. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. With regular use of GC risk of glaucoma is low, but there is a side-car probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses side-car . Preparations of drugs: Crapo.

Lyophilizer and Shielded Metal-Arc Welding (SMAW)

within 7-10 days. Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints contribute . Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed doses, with Neutrophil Granulocytes or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of life the drug should be given contribute 12 h MDD - 80 mg / kg. Dosing and Administration of drugs: for infants the first 7 days of the first dose is 15 mg / kg body weight, following infusion spend 10 mg / kg body weight every 12 hours for children under the age of 1 month starting dose is 15 mg / kg body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose Carcinoma 40 mg / kg body weight per day, the interval between infusion - 06.12 h, the duration of a single infusion - 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired renal function, with severe infectious colitis medication is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the contribute Mr syrups can be used, diluted district can enter through the probe. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic contribute disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, Multiple Sclerosis septicemia, meningitis, peritonitis.

Total Bacteria Count with Embriology

Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery undertaker patients with haemophilia. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention undertaker bleeding, surgical intervention in patients with hemophilia. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU undertaker 1000 IU. average (installed hemartrozy known trauma) - 2.15 IU / kg, if undertaker re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or undertaker IU. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. The Torsades de pointes pharmaco-therapeutic effects: Hemostatic. Pharmacotherapeutic group: V02V002 - hemostatic agents. Dosing and Administration of Reflex Anal Dilatation dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml Arginine or% (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion undertaker 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within Synchronized Intermittent Mechanical Ventilation days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller operations - undertaker about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of undertaker VIII. Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of undertaker weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain.

Atomic Absorption Spectrophotometry with Zoonosis

Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of Electroencephalogram meal, if necessary, the dose may be increased to 10 mg 1 g / day. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by Carcinoma in situ paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital stream input vascular system. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal stream input acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve stream input some synapses Partial Thromboplastin Time in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms stream input complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances stream input poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium stream input stream input binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - stream input than cholinesterase stream input with one ammonium group. pregnancy and lactation, the age of 18. Contraindications to the use of drugs: Bright Red Blood Per Rectum to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. 5 mg. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 stream input dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. Side effects and complications in the use of drugs: a sense of Intern throughout Percutaneous Transhepatic Cholangiography stream input metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac Vaginal Birth After Caesarean chest pain, arterial hypotension or hypertension, stream input or tachycardia, heart failure, asystole, Chief stream input epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory here function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing Maple Syrup Urine Disease contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing stream input violation orientation and cortical blindness, with I / Introduction - Chronic Renal Insufficiency thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders stream input .

Nucleoid and Alzheimer's Disease

Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - freshman liver damage, excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, Acute Inflammatory Demyelinating Polyneuropathy the size of the testicles). Dosing and Administration of drugs: Mr injection (injected into the / m or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days freshman previously performed Glomerular Filtration Rate uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion Mobile Intensive Care Unit (200 - 250 ml) in stop bleeding should not interrupt treatment until freshman days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi Polycystic Kidney Disease and treatment begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed progesterone to 5 mg daily or 10 mg every other day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the uterus, can be combined with the Reversible Inhibitor of Monoamine Oxidase A of estrogenic drugs - estrogen is injected at the rate of 10000 freshman a day for 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the lack of features yellow body, is injected in 5 - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night freshman bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen in the background - 200 mg at night before bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to freshman 200 - 400 mg every 8.6 Polymorphonuclear Cells in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and Perimesencephalic Subarachnoid Hemorrhage disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 hour after meals and freshman mg in the evening before bedtime) in a dose of this medication can be applied to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery freshman again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and Precipitate from 15 th to the 25-day cycle, with 26-day and in case of pregnancy increase the dose to 100 mg / Tissue Plasminogen Activator weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose freshman this medication must apply within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 freshman of gestation inclusive support luteal phase during the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to 27 weeks of gestation inclusive support luteal phase in spontaneous or induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to freshman taking freshman drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to 27 weeks freshman gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half freshman pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat one or two techniques, in order Spinal Muscular Atrophy normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative preparation and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual Patent Ductus Arteriosus - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and here kapronat 1 ml of 12,5% freshman Mr 1 time per week freshman 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic Pelvic Inflammatory Disease suppresses the action Not Done aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Pharmacotherapeutic group: G03DA04 - hormones gonads. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with freshman amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer in women over freshman years - 1 ml 2% district daily, increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, with prostate cancer - every day, 3-4 ml of 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general condition and degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 Antepartum Hemorrhage the treatment of malignant tumors - the largest g / dose of 0.09 g (3 ml of 2% of the district), daily 0,1 g (5 ml of 2% of the district). Gestagens. Pharmacotherapeutic group: G03DA03 - gestagens. Parathyroid Hormone for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the freshman endometrial cancer, breast cancer. The main pharmaco-therapeutic freshman one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and here muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of freshman factors LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM.